Lixisenatide - Therapy in Patients with Type-2-Diabetes and acute Coronary Syndrome

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Univ Dusseldorf, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2016年 / 12卷 / 01期
关键词：
D O I：
10.1007/s11428-015-0055-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [31] Lixisenatide for Type 2 Diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1513): : 1 - 3
  • [32] Update: new forms of therapy for type-2-diabetes
    Fischli, Stefan
    [J]. THERAPEUTISCHE UMSCHAU, 2020, 77 (07) : 319 - 327
  • [33] Lixisenatide and type 2 diabetes
    不详
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (09): : 309 - 309
  • [34] Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome
    Avogaro, Angelo
    Bonora, Enzo
    Consoli, Agostino
    Del Prato, Stefano
    Genovese, Stefano
    Giorgino, Francesco
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (05): : 399 - 414
  • [35] Gene Type-2-Diabetes A Portal helps to understand Type-2-Diabetes better
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (04): : 258 - 258
  • [36] Antiplatelet therapy for patients with diabetes mellitus and acute coronary syndrome
    Saucedo, Jorge Felix
    [J]. PRIMARY CARE DIABETES, 2012, 6 (03) : 167 - 177
  • [37] Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
    Farhan, S.
    Tentzeris, I.
    Freynhofer, M. K.
    Vogel, B.
    Huber, K.
    [J]. HERZ, 2012, 37 (03) : 264 - 272
  • [38] Is it worth the intensive Setting for Patients with Type-2-Diabetes?
    Weiss, Johannes
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (44) : 2224 - 2224
  • [39] Practical Recommendations GDS/GSIM Therapy of Type-2-Diabetes
    Landgraf, R.
    Kellerer, M.
    Fach, E.
    Gallwitz, B.
    Hamann, A.
    Joost, H. G.
    Klein, H. H.
    Mueller-Wieland, D.
    Nauck, M. A.
    Reuter, H. M.
    Schreiber, S.
    Siegel, E.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2016, 11 : S117 - S129
  • [40] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
12345